Literature DB >> 3288867

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.

S M Grundy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3288867     DOI： 10.1056/NEJM198807073190105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  116 in total

Review 1.  Drug interactions and the statins.

Authors:  R J Herman
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

2.  Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.

Authors:  B G Jacob; W Möhrle; W O Richter; P Schwandt
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.

Authors:  H Cheng; J D Rogers; A E Sweany; M R Dobrinska; E A Stein; A C Tate; R D Amin; H Quan
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

4.  Investigations on the mechanism of the hypocholesterolemic action of 1-ethoxysilatrane.

Authors:  P P Mehta; T Ramasarma; C K Kurup
Journal:  Mol Cell Biochem       Date:  1990-09-03       Impact factor: 3.396

Review 5.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

6.  Rhabdomyolysis associated with lovastatin and erythromycin use.

Authors:  D H Spach; J E Bauwens; C D Clark; W G Burke
Journal:  West J Med       Date:  1991-02

7.  Myopathic effects of lovastatin.

Authors:  W N Suki
Journal:  West J Med       Date:  1991-02

8.  LDL cholesterol performance of beta quantification reference measurement procedure.

Authors:  Masakazu Nakamura; Yuzo Kayamori; Hiroyasu Iso; Akihiko Kitamura; Masahiko Kiyama; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Hiroyuki Noda; Mahnaz Dasti; Hubert W Vesper; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2014-02-28       Impact factor: 3.786

9.  Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects.

Authors:  A R Miserez; F A Rossi; U Keller
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Lipoprotein lipase activity in patients with combined hyperlipidaemia.

Authors:  M Seed; F Mailly; D Vallance; E Doherty; A Winder; P Talmud; S E Humphries
Journal:  Clin Investig       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.